Insulin-Degrading Enzyme

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
<StructureSection load="3tuv" size="400" color="" frame="true" spin="on" Scene= align="right" caption='Rat insulin-degrading enzyme complex with peptide (green) and ATP, [[3tuv]]' >
<StructureSection load="3tuv" size="400" color="" frame="true" spin="on" Scene= align="right" caption='Rat insulin-degrading enzyme complex with peptide (green) and ATP, [[3tuv]]' >
[[Image:2g49.png|left|200px]]
[[Image:2g49.png|left|200px]]
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
[[Insulin-Degrading Enzyme]] (PDB entry [[2g49]]) is a highly conserved 2*113 kDa homodimeric zinc metalloprotease. It belongs to the M16A family of metalloproteases within the ME clan. It hydrolyses insulin and several amyloidogenic peptides like amyloid-β (Aβ).
[[Insulin-Degrading Enzyme]] (PDB entry [[2g49]]) is a highly conserved 2*113 kDa homodimeric zinc metalloprotease. It belongs to the M16A family of metalloproteases within the ME clan. It hydrolyses insulin and several amyloidogenic peptides like amyloid-β (Aβ).
Line 27: Line 8:
IDE could help creating IDE-based therapies to control cerebral Aβ and blood sugar concentrations thanks to the understanding of its molecular mechanisms.
IDE could help creating IDE-based therapies to control cerebral Aβ and blood sugar concentrations thanks to the understanding of its molecular mechanisms.
IDE is an unusual enzyme because of its high affinity for substrates that are widely diverse in sequence and structure. IDE prefers to degrade <6 kDa bioactive peptides such as insulin, Aβ, glucagon, atrial natriuretic peptides or transforming growth factor α. Paradoxally, even though IDE targets a broad range of substrates, it shows a remarkable capacity to selectively cleave some peptides without degrading related family members.
IDE is an unusual enzyme because of its high affinity for substrates that are widely diverse in sequence and structure. IDE prefers to degrade <6 kDa bioactive peptides such as insulin, Aβ, glucagon, atrial natriuretic peptides or transforming growth factor α. Paradoxally, even though IDE targets a broad range of substrates, it shows a remarkable capacity to selectively cleave some peptides without degrading related family members.
- 
== How are the structure and the functions of IDE related? ==
== How are the structure and the functions of IDE related? ==
- 
=== Structure general points ===
=== Structure general points ===
Line 59: Line 38:
The enclosed substrate undergoes conformational changes to form β-sheets with two discrete regions of IDE for its degradation.
The enclosed substrate undergoes conformational changes to form β-sheets with two discrete regions of IDE for its degradation.
IDE-N and IDE-C have extensive interactions that bury a large surface of 11,496 Ȧ<sup>2</sup> with good shape complementarity and numerous hydrogen bonds. In the absence of interactions with factors or proteins, the substrate-free IDE-c state is stable and the catalytic chamber of IDE is mostly closed. So we can consider that IDE-c is the resting and inactive state of IDE.
IDE-N and IDE-C have extensive interactions that bury a large surface of 11,496 Ȧ<sup>2</sup> with good shape complementarity and numerous hydrogen bonds. In the absence of interactions with factors or proteins, the substrate-free IDE-c state is stable and the catalytic chamber of IDE is mostly closed. So we can consider that IDE-c is the resting and inactive state of IDE.
-
 
+
</StructureSection>
 +
__NOTOC__
==3D structures of insulin-degrading enzyme==
==3D structures of insulin-degrading enzyme==

Revision as of 09:02, 20 November 2013

Rat insulin-degrading enzyme complex with peptide (green) and ATP, 3tuv

Drag the structure with the mouse to rotate

3D structures of insulin-degrading enzyme

Updated on 20-November-2013

2jg4 - hIDE (mutant) – human
3qz2 - hIDE
3p7l - rIDE – rat

Insulin-degrading enzyme complexes

3n56, 3n57 – hIDE (mutant) + B-type natriuretic peptide
2yb3 - hIDE (mutant) + inhibitor
3ofi - hIDE + ubiquitin
3h44 - hIDE (mutant) + C-C motif chemokine 3
3hgz, 2g48 - hIDE (mutant) + amylin
3e4z - hIDE (mutant) + insulin-like growth factor II
3e50 - hIDE (mutant) + Transforming growth factor α
3e4a – hIDE (mutant) + hydroxamate peptide II1
2wby, 2wc0 - hIDE (mutant) + insulin
3cww - hIDE (mutant) + Bradykinin N terminal peptide
2jbu - hIDE (mutant) + co-purified peptide
2g47, 2wk3 - hIDE (mutant) + amyloid β A4
2g49 - hIDE (mutant) + glucagons
2g54 - hIDE (mutant) + insulin β chain + Zn
2g56 - hIDE + insulin β chain residues 25-54
2ypu, 4dtt, 4dwk – hIDE + inhibitor
3p7o - rIDE (mutant) + peptide
4iof – hIDE + antibody
3tuv - rIDE + peptide + ATP </StructureSection>

References

  • Im H, Manolopoulou M, Malito E, Shen Y, Zhao J, Neant-Fery M, Sun CY, Meredith SC, Sisodia SS, Leissring MA, Tang WJ. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Biol Chem. 2007 Aug 31;282(35):25453-63. Epub 2007 Jul 5. PMID:17613531 doi:10.1074/jbc.M701590200
  • Shen Y, Joachimiak A, Rosner MR, Tang WJ. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature. 2006 Oct 19;443(7113):870-4. Epub 2006 Oct 11. PMID:17051221 doi:10.1038/nature05143
  • Li P, Kuo WL, Yousef M, Rosner MR, Tang WJ. The C-terminal domain of human insulin degrading enzyme is required for dimerization and substrate recognition. Biochem Biophys Res Commun. 2006 May 19;343(4):1032-7. Epub 2006 Mar 22. PMID:16574064 doi:10.1016/j.bbrc.2006.03.083
Personal tools